{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:11:51Z","timestamp":1785442311836,"version":"3.56.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.urolonc.2009.07.020","type":"journal-article","created":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T04:36:59Z","timestamp":1256877419000},"page":"653-667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"title":["Bladder cancer in the elderly"],"prefix":"10.1016","volume":"27","author":[{"given":"Shahrokh F.","family":"Shariat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Milowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Droller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2009.07.020_bib2","first-page":"1","article-title":"What drives U.S. population growth?","volume":"57","author":"Kent","year":"2002","journal-title":"Population Bull"},{"key":"10.1016\/j.urolonc.2009.07.020_bib3","series-title":"An aging world: 2005 U.S. census bureau, series P95\/005\u20131","author":"Kinsella","year":"2005"},{"key":"10.1016\/j.urolonc.2009.07.020_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.seminoncol.2003.12.024","article-title":"Cancer in older persons: An international issue in an aging world","volume":"31","author":"Yancik","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib6","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/1097-0142(19941001)74:7+<1995::AID-CNCR2820741702>3.0.CO;2-Y","article-title":"Cancer in older persons","volume":"74","author":"Yancik","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2009.07.020_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0889-8588(05)70275-6","article-title":"Aging and cancer in America","volume":"14","author":"Yancik","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.urolonc.2009.07.020_bib8","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/cncr.10593","article-title":"Annual report to the nation on the status of cancer, 1973\u20131999, featuring implications of age and aging on U.S. cancer burden","volume":"94","author":"Edwards","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2009.07.020_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/gerona\/58.1.M82","article-title":"Cancer survivors in the United States: Age, health, and disability","volume":"58","author":"Hewitt","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.urolonc.2009.07.020_bib10","series-title":"SEER cancer statistics review, 1975\u20132002","author":"Edwards","year":"2005"},{"key":"10.1016\/j.urolonc.2009.07.020_bib11","first-page":"434","article-title":"Age-related physiologic changes and their clinical significance","volume":"135","author":"Boss","year":"1981","journal-title":"West J Med"},{"key":"10.1016\/j.urolonc.2009.07.020_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1474-9726.2008.00383.x","article-title":"Aging and cancer cell biology, 2008","volume":"7","author":"Campisi","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.urolonc.2009.07.020_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOU.0b013e3282f1c5c1","article-title":"Molecular markers in bladder cancer","volume":"18","author":"Shariat","year":"2008","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1586\/14737140.8.7.1103","article-title":"Predicting tumor outcomes in urothelial bladder carcinoma: Turning pathways into clinical biomarkers of prognosis","volume":"8","author":"Ehdaie","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.urolonc.2009.07.020_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrc1697","article-title":"Urothelial tumorigenesis: A tale of divergent pathways","volume":"5","author":"Wu","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2009.07.020_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1067\/mgn.2000.107137","article-title":"Medicate with caution to prevent problems in frail elders","volume":"21","author":"Miller","year":"2000","journal-title":"Geriatr Nurs"},{"key":"10.1016\/j.urolonc.2009.07.020_bib17","series-title":"Cancer Medicine","article-title":"Cancer and Aging (Chapter 75)","author":"Hurria","year":"2003"},{"key":"10.1016\/j.urolonc.2009.07.020_bib18","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/jnci\/dji289","article-title":"Annual report to the nation on the status of cancer, 1975\u20132002, featuring population-based trends in cancer treatment","volume":"97","author":"Edwards","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2009.07.020_bib19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00130404-200511000-00004","article-title":"Physiologic aspects of aging: Impact on cancer management and decision making, part I","volume":"11","author":"Sawhney","year":"2005","journal-title":"Cancer J"},{"key":"10.1016\/j.urolonc.2009.07.020_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00130404-200511000-00005","article-title":"Physiologic aspects of aging: Impact on cancer management and decision making, part II","volume":"11","author":"Sehl","year":"2005","journal-title":"Cancer J"},{"key":"10.1016\/j.urolonc.2009.07.020_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0002-9343(92)90200-U","article-title":"Value of functional status as a predictor of mortality: Results of a prospective study","volume":"93","author":"Reuben","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.urolonc.2009.07.020_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.urolonc.2009.07.020_bib24","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1532-5415.2001.49258.x","article-title":"Weight change in old age and its association with mortality","volume":"49","author":"Newman","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.urolonc.2009.07.020_bib25","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.amjmed.2008.05.019","article-title":"Management of hypertension and cerebrovascular disease in the elderly","volume":"121","author":"Pedelty","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.urolonc.2009.07.020_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1524-6175.2004.03307.x","article-title":"Hypertension and the elderly: More than just blood pressure control","volume":"6","author":"Baruch","year":"2004","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.urolonc.2009.07.020_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/ciia.2006.1.3.253","article-title":"Effect of aging on respiratory system physiology and immunology","volume":"1","author":"Sharma","year":"2006","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.urolonc.2009.07.020_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MED.0b013e3282fc7049","article-title":"Dehydroepiandrosterone in adrenal insufficiency and ageing","volume":"15","author":"Bhagra","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"Suppl 14","key":"10.1016\/j.urolonc.2009.07.020_bib29","first-page":"63","article-title":"Androgen deficiency in the aging male: A guide to diagnosis and testosterone replacement therapy","volume":"1","author":"Raynor","year":"2007","journal-title":"Can J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ghir.2008.09.002","article-title":"The aging population: Is there a role for endocrine interventions?","volume":"19","author":"Nass","year":"2009","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.urolonc.2009.07.020_bib31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.neubiorev.2008.03.005","article-title":"What do we know about the long-term consequences of stress on ageing and the progression of age-related neurodegenerative disorders?","volume":"32","author":"Pardon","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.urolonc.2009.07.020_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MJT.0b013e3180ed6b8f","article-title":"Hypertension and cognitive function in the elderly","volume":"14","author":"Cherubini","year":"2007","journal-title":"Am J Ther"},{"key":"10.1016\/j.urolonc.2009.07.020_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1532-5415.1996.tb00908.x","article-title":"Cognitive impairment and risk of stroke in the older population","volume":"44","author":"Ferrucci","year":"1996","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.urolonc.2009.07.020_bib34","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.2007.10.6559","article-title":"Comprehensive geriatric assessment for older patients with cancer","volume":"25","author":"Extermann","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/ciia.2007.2.1.33","article-title":"Immunosupportive therapies in aging","volume":"2","author":"Fulop","year":"2007","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.urolonc.2009.07.020_bib36","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1189\/jlb.0108023","article-title":"Age-associated changes in immune and inflammatory responses: Impact of vitamin E intervention","volume":"84","author":"Wu","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14760584.7.4.467","article-title":"Age-related decline in immunity: Implications for vaccine responsiveness","volume":"7","author":"Kumar","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.urolonc.2009.07.020_bib38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/529197","article-title":"Biology of immune responses to vaccines in elderly persons","volume":"46","author":"Weinberger","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.urolonc.2009.07.020_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.exger.2005.06.009","article-title":"Age-related changes in liver structure and function: Implications for disease?","volume":"40","author":"Schmucker","year":"2005","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000052829","article-title":"The aging liver: Structural and functional changes and their consequences for drug treatment in old age","volume":"48","author":"Zeeh","year":"2002","journal-title":"Gerontology"},{"key":"10.1016\/j.urolonc.2009.07.020_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000022097","article-title":"Age-dependent changes of the kidneys: Pharmacological implications","volume":"45","author":"Muhlberg","year":"1999","journal-title":"Gerontology"},{"key":"10.1016\/j.urolonc.2009.07.020_bib42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","article-title":"When drug therapy gets old: Pharmacokinetics and pharmacodynamics in the elderly","volume":"38","author":"Turnheim","year":"2003","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/00365590310015750","article-title":"Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance","volume":"38","author":"Fehrman-Ekholm","year":"2004","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/dis.2008.111720","article-title":"Disease management in the frail and elderly population: Integration of physicians in the intervention","volume":"11","author":"Want","year":"2008","journal-title":"Dis Manage"},{"key":"10.1016\/j.urolonc.2009.07.020_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/107327480701400102","article-title":"Aging, frailty, and chemotherapy","volume":"14","author":"Balducci","year":"2007","journal-title":"Cancer Control"},{"key":"10.1016\/j.urolonc.2009.07.020_bib46","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: Evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.urolonc.2009.07.020_bib47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0025-7125(05)70157-7","article-title":"Frailty and the older man","volume":"83","author":"Walston","year":"1999","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.urolonc.2009.07.020_bib48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1047-2797(96)00063-4","article-title":"Cancer and comorbidity in older patients: A descriptive profile","volume":"6","author":"Yancik","year":"1996","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1040-8428(00)00090-1","article-title":"Measurement and impact of comorbidity in older cancer patients","volume":"35","author":"Extermann","year":"2000","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib50","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-120-2-199401150-00002","article-title":"The effect of comorbidity on 3-year survival of women with primary breast cancer","volume":"120","author":"Satariano","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2009.07.020_bib51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-124-6-199603150-00007","article-title":"Estimating treatment benefits for the elderly: The effect of competing risks","volume":"124","author":"Welch","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2009.07.020_bib52","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.amjopharm.2004.12.005","article-title":"Pharmacokinetics in older persons","volume":"2","author":"Cusack","year":"2004","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.urolonc.2009.07.020_bib53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1037\/0882-7974.5.1.58","article-title":"Tenacious goal pursuit and flexible goal adjustment: Explication and age-related analysis of assimilative and accommodative strategies of coping","volume":"5","author":"Brandtstadter","year":"1990","journal-title":"Psychol Aging"},{"key":"10.1016\/j.urolonc.2009.07.020_bib54","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1467-6494.2004.00301.x","article-title":"Socioemotional selectivity theory, aging, and health: The increasingly delicate balance between regulating emotions and making tough choices","volume":"72","author":"Lockenhoff","year":"2004","journal-title":"J Pers"},{"key":"10.1016\/j.urolonc.2009.07.020_bib55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pec.2006.04.002","article-title":"Age: Nuisance variable to be eliminated with statistical control or important concern?","volume":"61","author":"Sanderman","year":"2006","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.urolonc.2009.07.020_bib56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.critrevonc.2006.03.007","article-title":"Geriatric assessment for oncologists: Rationale and future directions","volume":"59","author":"Hurria","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib57","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/35041694","article-title":"The age of cancer","volume":"408","author":"DePinho","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2009.07.020_bib58","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1200\/JCO.2007.10.8928","article-title":"Science of cancer and aging","volume":"25","author":"Irminger-Finger","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tig.2007.11.004","article-title":"Age to survive: DNA damage and aging","volume":"24","author":"Schumacher","year":"2008","journal-title":"Trends Genet"},{"key":"10.1016\/j.urolonc.2009.07.020_bib60","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4161\/cc.7.7.5657","article-title":"The tumor suppressor p53: Cancer and aging","volume":"7","author":"Feng","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.urolonc.2009.07.020_bib61","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1046\/j.1432-1327.2001.02228.x","article-title":"Regulation of cellular senescence by p53","volume":"268","author":"Itahana","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.urolonc.2009.07.020_bib62","first-page":"155","article-title":"Analysis of tumor suppressor gene-induced senescence","volume":"223","author":"Campisi","year":"2003","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib63","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/bies.10111","article-title":"p53 and aging: Too much of a good thing?","volume":"24","author":"Kirkwood","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.urolonc.2009.07.020_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2006.05.017","article-title":"Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis","author":"Shariat","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib65","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM199411103311903","article-title":"Accumulation of nuclear p53 and tumor progression in bladder cancer","volume":"331","author":"Esrig","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2009.07.020_bib66","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0891-5849(03)00316-2","article-title":"ROS in the local and systemic pathogenesis of COPD","volume":"35","author":"Langen","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.urolonc.2009.07.020_bib67","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/excr.1995.1306","article-title":"Telomere shortening is associated with cell division in vitro and in vivo","volume":"220","author":"Allsopp","year":"1995","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.urolonc.2009.07.020_bib68","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ng0796-350","article-title":"Accelerated telomere shortening in ataxia telangiectasia","volume":"13","author":"Metcalfe","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2009.07.020_bib69","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrc2393","article-title":"Telomere dysfunction and tumor suppression: The senescence connection","volume":"8","author":"Deng","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2009.07.020_bib70","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1073\/pnas.112515399","article-title":"Constitutive telomerase expression promotes mammary carcinomas in aging mice","volume":"99","author":"Artandi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urolonc.2009.07.020_bib71","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/78595","article-title":"Mice without telomerase: What can they teach us about human cancer?","volume":"6","author":"Artandi","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.urolonc.2009.07.020_bib72","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1126\/science.283.5404.947","article-title":"Unlimited mileage from telomerase?","volume":"283","author":"de Lange","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2009.07.020_bib73","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2174\/092986706778521887","article-title":"Telomerase inhibition in cancer therapeutics: Molecular-based approaches","volume":"13","author":"Cunningham","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.urolonc.2009.07.020_bib74","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0531-5565(01)00160-7","article-title":"Cellular senescence, cancer, and aging: The telomere connection","volume":"36","author":"Campisi","year":"2001","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib75","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1566524053586626","article-title":"Telomeres, telomerase, and malignant transformation","volume":"5","author":"Opitz","year":"2005","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.urolonc.2009.07.020_bib76","first-page":"1603","article-title":"Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer","volume":"4","author":"Ito","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2009.07.020_bib77","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2009.07.020_bib78","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jnci\/djg011","article-title":"Telomere dysfunction: A potential cancer predisposition factor","volume":"95","author":"Wu","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2009.07.020_bib79","first-page":"217","article-title":"Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer","volume":"60","author":"Herman","year":"2008","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib80","series-title":"Urology","first-page":"2407","article-title":"Urothelial tumors of the bladder (Chapter 75)","author":"Messing","year":"2008"},{"key":"10.1016\/j.urolonc.2009.07.020_bib81","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2009.07.020_bib82","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.urology.2008.01.062","article-title":"Relationship between patient age and superficial transitional cell carcinoma characteristics","volume":"71","author":"Shi","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.07.020_bib83","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/aje\/kwj028","article-title":"Hormonal and reproductive factors and the risk of bladder cancer in women","volume":"163","author":"McGrath","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib84","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.juro.2007.11.079","article-title":"Late age (85 years or older) peak incidence of bladder cancer","volume":"179","author":"Schultzel","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib85","first-page":"5487","article-title":"Tumor-promoting effect of urinary epidermal growth factor in rat urinary bladder carcinogenesis","volume":"51","author":"Momose","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2009.07.020_bib86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)50950-7","article-title":"Transitional cell carcinoma of the bladder in children and adolescents","volume":"130","author":"Benson","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-5347(17)45513-3","article-title":"Bladder carcinoma in patients 40 years old or less","volume":"135","author":"Fitzpatrick","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib88","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/00005392-199805000-00022","article-title":"The molecular characteristics of bladder cancer in young patients","volume":"159","author":"Linn","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib89","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0022-5347(17)42721-2","article-title":"Long-term follow-up of patients less than 30 years old with transitional cell carcinoma of bladder","volume":"139","author":"Madgar","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib90","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000281475","article-title":"Bladder carcinoma in patients less than 40 years of age","volume":"44","author":"Witjes","year":"1989","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2009.07.020_bib91","article-title":"The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy","author":"Resorlu","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2009.07.020_bib92","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.eururo.2006.11.004","article-title":"Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy","volume":"51","author":"Nielsen","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib93","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0022-5347(17)57090-1","article-title":"Carcinoma of the bladder in patients less than 40 years old","volume":"120","author":"Johnson","year":"1978","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib94","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0022-5347(17)44046-8","article-title":"The natural history of patients less than 40 years old with bladder tumors","volume":"137","author":"Kurz","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib95","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-410X.1993.tb16261.x","article-title":"Transitional cell carcinoma of the bladder in young adults","volume":"72","author":"Kutarski","year":"1993","journal-title":"Br J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib96","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/1097-0142(19890701)64:1<178::AID-CNCR2820640130>3.0.CO;2-B","article-title":"Bladder carcinoma in patients age 40 years or younger","volume":"64","author":"Wan","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2009.07.020_bib97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-5347(05)64832-X","article-title":"Transitional cell carcinoma of the bladder in young adults: Presentation, natural history, and outcome","volume":"168","author":"Yossepowitch","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib98","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2006.05.003","article-title":"Aging and innate immunity","volume":"24","author":"Solana","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.urolonc.2009.07.020_bib99","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.urology.2007.03.024","article-title":"Age and outcome of superficial bladder cancer treated with bacille Calmette-Guerin therapy","volume":"70","author":"Herr","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.07.020_bib100","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0022-5347(05)00973-0","article-title":"The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy","volume":"175","author":"Joudi","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib101","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/01.TP.0000090748.32764.0F","article-title":"Intravesical bacillus Calmette-Guerin for the treatment of superficial bladder cancer in renal transplant patients","volume":"76","author":"Palou","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.urolonc.2009.07.020_bib102","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.juro.2006.03.066","article-title":"Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients","volume":"176","author":"Yossepowitch","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib103","series-title":"Campbell's Urology","first-page":"2789","article-title":"Management of superficial bladder cancer","author":"Malkowicz","year":"2002"},{"key":"10.1016\/j.urolonc.2009.07.020_bib104","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/S0022-5347(17)37062-3","article-title":"Complications of intravesical bacillus Calmette-Guerin: A case report","volume":"148","author":"Gonzalez","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gut.38.4.616","article-title":"Granulomatous hepatitis caused by bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation","volume":"38","author":"Leebeek","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.urolonc.2009.07.020_bib106","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-5347(17)43892-4","article-title":"Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma","volume":"137","author":"Marans","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib107","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1442-2042.2003.00704.x","article-title":"Acute eosinophilic pneumonia associated with intravesical bacillus Calmette-Guerin therapy of carcinoma in situ of the bladder","volume":"10","author":"Orikasa","year":"2003","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib108","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0022-5347(17)39731-8","article-title":"Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer","volume":"144","author":"Rawls","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib109","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.urolonc.2007.04.005","article-title":"Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guerin therapy","volume":"26","author":"Heiner","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib110","first-page":"3726","article-title":"Modulation of fibronectin-mediated bacillus Calmette-Guerin attachment to murine bladder mucosa by drugs influencing the coagulation pathways","volume":"51","author":"Hudson","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2009.07.020_bib111","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0022-5347(17)39741-0","article-title":"Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors","volume":"144","author":"Hudson","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib112","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1445-2197.1993.tb00060.x","article-title":"The adverse effect of fibrin-clot inhibiting drugs on intravesical bacillus Calmette-Guerin efficacy for superficial bladder cancer","volume":"63","author":"P'Ng","year":"1993","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.urolonc.2009.07.020_bib113","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib114","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.juro.2006.08.004","article-title":"Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: A contemporary series from the bladder cancer research consortium","volume":"176","author":"Shariat","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib115","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2009.07.020_bib116","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib117","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eururo.2005.04.005","article-title":"Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration","volume":"48","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib118","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration","volume":"48","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib119","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2005.03.025","article-title":"Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: Literature review","volume":"48","author":"Pectasides","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib120","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1200\/JCO.1994.12.7.1394","article-title":"Neoadjuvant chemotherapy for invasive bladder cancer: Prognostic factors for survival of patients treated with M-VAC with 5-year follow-up","volume":"12","author":"Schultz","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib121","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.critrevonc.2005.05.004","article-title":"Perioperative chemotherapy for bladder cancer","volume":"57","author":"Sonpavde","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib122","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/cncr.21354","article-title":"Age and comorbidity impact surgical therapy in older bladder carcinoma patients: A population-based study","volume":"104","author":"Prout","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2009.07.020_bib123","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.urology.2004.03.034","article-title":"Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older","volume":"64","author":"Hollenbeck","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.07.020_bib124","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1200\/JCO.2006.10.3457","article-title":"Adjuvant therapy in the elderly: Making the right decision","volume":"25","author":"Muss","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cncr.21126","article-title":"Radical cystectomy in the elderly: Comparison of clinical outcomes between younger and older patients","volume":"104","author":"Clark","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2009.07.020_bib126","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.eururo.2006.11.004","article-title":"Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy","volume":"51","author":"Nielsen","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib127","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/1097-0142(19940315)73:6<1708::AID-CNCR2820730626>3.0.CO;2-J","article-title":"Clinical variables, which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate","volume":"73","author":"Thrasher","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2009.07.020_bib128","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1464-410X.2007.07132.x","article-title":"A delay in radical cystectomy of more than 3 months is not associated with a worse clinical outcome","volume":"100","author":"Nielsen","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2009.07.020_bib129","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.ju.0000086828.26001.ca","article-title":"Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathologic stage","volume":"170","author":"Chang","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-5347(05)64047-5","article-title":"An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma","volume":"169","author":"Sanchez-Ortiz","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-5347(05)64046-3","article-title":"The impact of comorbid disease on cancer control and survival following radical cystectomy","volume":"169","author":"Miller","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib132","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/cncr.23462","article-title":"Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer","volume":"112","author":"Kopie","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2009.07.020_bib133","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.juro.2006.11.060","article-title":"Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer","volume":"177","author":"Weizer","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib134","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.2003.05.101","article-title":"Radical cystectomy for bladder cancer today\u2014a homogeneous series without neoadjuvant therapy","volume":"21","author":"Madersbacher","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib135","article-title":"Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology","author":"Shabsigh","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib136","article-title":"Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: A high-volume tertiary cancer center experience","author":"Donat","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib137","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1464-410x.2000.00454.x","article-title":"The changing pattern of mortality and morbidity from radical cystectomy","volume":"85","author":"Rosario","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2009.07.020_bib138","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0090-4295(99)00619-6","article-title":"Continent urinary reconstruction vs. ileal conduit: A contemporary single-institution comparison of perioperative morbidity and mortality","volume":"55","author":"Parekh","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.07.020_bib139","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.urolonc.2003.12.005","article-title":"Benefit of radical cystectomy in the elderly patient with significant comorbidities","volume":"22","author":"Farnham","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<141::AID-CNCR19>3.0.CO;2-X","article-title":"Radical cystectomy for elderly patients with bladder carcinoma: An updated experience with 404 patients","volume":"83","author":"Figueroa","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2009.07.020_bib141","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/S0022-5347(05)64166-3","article-title":"Orthotopic neobladder following radical cystectomy in patients with high perioperative risk and comorbid medical conditions","volume":"168","author":"Parekh","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib142","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.juro.2008.03.057","article-title":"Associations among age, comorbidity, and clinical outcomes after radical cystectomy: Results from the Alberta Urology Institute radical cystectomy database","volume":"180","author":"Fairey","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib143","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/01.ju.0000154638.61621.03","article-title":"Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: Data from the health care utilization project","volume":"173","author":"Konety","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib144","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/01.ju.0000173923.35338.99","article-title":"Identifying risk factors for potentially avoidable complications following radical cystectomy","volume":"174","author":"Hollenbeck","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-5347(09)61777-8","article-title":"Radical cystectomy (RC) in octogenarians: Does morbidity outweigh the potential survival benefits?","volume":"181","author":"Siegrist","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib146","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1200\/JCO.2001.19.1.89","article-title":"Transurethral resection of muscle-invasive bladder cancer: Ten-year outcome","volume":"19","author":"Herr","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib147","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0022-5347(06)00322-3","article-title":"Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: A contemporary review of the M. D. Anderson Cancer Center experience","volume":"175","author":"Kassouf","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib148","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/01.ju.0000135530.59860.7d","article-title":"Partial cystectomy: A contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection","volume":"172","author":"Holzbeierlein","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib149","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/clon.2003.0227","article-title":"Surgery vs. radiotherapy for muscle invasive bladder cancer?","volume":"15","author":"Shelley","year":"2003","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.urolonc.2009.07.020_bib150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.semradonc.2004.07.008","article-title":"Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates\u2014the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences","volume":"15","author":"Shipley","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib151","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/01.ju.0000093721.23249.c3","article-title":"Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy, and radiation: Results of a urodynamic and quality of life study on long-term survivors","volume":"170","author":"Zietman","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib152","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1200\/JCO.1997.15.3.1022","article-title":"Bladder preservation by combined modality therapy for invasive bladder cancer","volume":"15","author":"Kachnic","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib153","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0022-5347(05)68584-9","article-title":"Against bladder sparing Surgery","volume":"162","author":"Montie","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib154","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0022-5347(01)68171-0","article-title":"Radical cystectomy in the octogenarian","volume":"158","author":"Stroumbakis","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib155","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.urology.2007.11.125","article-title":"Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer","volume":"71","author":"Sogni","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2009.07.020_bib156","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0022-5347(05)65082-3","article-title":"Long-term voiding pattern of patients with ileal orthotopic bladder substitutes","volume":"167","author":"Madersbacher","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib157","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-5347(17)35392-2","article-title":"The ileal neobladder: Six years of experience with more than 200 patients","volume":"150","author":"Hautmann","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib158","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0022-5347(01)61908-6","article-title":"Decreased sensitivity in the membranous urethra after orthotopic ileal bladder substitute","volume":"161","author":"Hugonnet","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib159","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.ju.0000138249.31644.ec","article-title":"Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution","volume":"172","author":"Kessler","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib160","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1200\/JCO.2007.10.6807","article-title":"The cancer aging interface: A research agenda","volume":"25","author":"Cohen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib161","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1200\/JCO.2007.10.6583","article-title":"International Society of Geriatric Oncology Chemotherapy Taskforce: Evaluation of chemotherapy in older patients\u2014an analysis of the medical literature","volume":"25","author":"Lichtman","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib162","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/annonc\/mdl178","article-title":"The illness trajectory of elderly cancer patients across cultures: SIOG position paper","volume":"18","author":"Surbone","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib163","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1040-8428(04)00138-6","article-title":"Statements on the interdependence between the oncologist and the geriatrician in geriatric oncology","volume":"52","author":"Terret","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib164","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.2006.10.3291","article-title":"Multidisciplinary approach to the geriatric oncology patient","volume":"25","author":"Terret","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2005.06.003","article-title":"Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)","volume":"55","author":"Extermann","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.urolonc.2009.07.020_bib166","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.clineuro.2005.03.008","article-title":"Incidence of ischemic stroke post-chemotherapy: A retrospective review of 10,963 patients","volume":"108","author":"Li","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.urolonc.2009.07.020_bib167","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/cncr.22031","article-title":"Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder","volume":"107","author":"Dash","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2009.07.020_bib168","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000080282","article-title":"Single-agent gemcitabine in previously untreated elderly patients with advanced bladder carcinoma: Response to treatment and correlation with the comprehensive geriatric assessment","volume":"67","author":"Castagneto","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.urolonc.2009.07.020_bib169","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000132394","article-title":"Biweekly carboplatin\/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: Report of efficacy, quality of life, and geriatric assessment","volume":"73","author":"Bamias","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.urolonc.2009.07.020_bib170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3816\/CLM.2001.n.011","article-title":"The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: A risk factor analysis","volume":"2","author":"Morrison","year":"2001","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.urolonc.2009.07.020_bib171","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/j.seminoncol.2003.12.028","article-title":"Surgery in older patients","volume":"31","author":"Kemeny","year":"2004","journal-title":"Semin Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814390900221X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814390900221X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:56:08Z","timestamp":1761040568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814390900221X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":168,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S107814390900221X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2009.07.020","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bladder cancer in the elderly","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2009.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}